NCT03980392

Brief Summary

This study evaluates acceptability and efficacy of multidomain intervention program to prevent cognitive impairment and protect brain health in Korean at-risk elderly. A third of participants will receive facility-based intervention for 6 months, a third will receive home-based intervention for 6 months, and a third is waiting list controls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
152

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2019

Completed
1 day until next milestone

Study Start

First participant enrolled

May 29, 2019

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 10, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 14, 2020

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2020

Completed
Last Updated

March 4, 2021

Status Verified

March 1, 2021

Enrollment Period

9 months

First QC Date

May 28, 2019

Last Update Submit

March 2, 2021

Conditions

Keywords

preventiondementiainterventionmild cognitive impairment

Outcome Measures

Primary Outcomes (3)

  • retention rate (percent) of the participants

    Retention rate in each intervention group

    6 months

  • compliance (percent)

    Compliance to the protocol in each intervention group

    6 months

  • Change of cognition

    Repeatable Battery for the Assessment of Neuropsychological Status (sum, range 40-160) / Higher scores mean better cognition.

    Change at 6 months from baseline

Secondary Outcomes (14)

  • Change of global cognition

    Change at 6 months from baseline

  • Change of function

    Change at 6 months from baseline

  • Change of depression

    Change at 6 months from baseline

  • Change of subjective memory complaints

    Change at 6 months from baseline

  • Change of memory complaints

    Change at 6 months from baseline

  • +9 more secondary outcomes

Study Arms (3)

Facility-based Intervention

EXPERIMENTAL

A group will consist of 5 or 10 persons depending on the size of the study center. Exercise training will be guided by study exercise therapists at a gym and consist of programs for progressive muscle strength training, aerobic exercise, and exercises to improve postural balance and flexibility using elastic bands, floor plate and chairs (three times per week, 60 min per session).The cognitive training program is a program including tasks to be effective in episodic memory, executive function, attention, working memory, calculation, and visuospatial function (twice per week, 60 min per session). The nutritional intervention is conducted by study nutritionists (three individual sessions and seven group sessions). Management of metabolic and vascular risk factors will include additional meetings with the study nurse (at 0, 4, 8, 16, and 20 weeks), and the study physician (at 0 and 12 weeks). Motivational training is conducted by psychologist (four group session).

Other: Multidomain intervention program

Home-based Intervention

EXPERIMENTAL

The nutritional intervention, management of metabolic and vascular risk factors, social activity, and motivational training in the home-based intervention are similar to the facility-based intervention. The physical exercise programs consist of one group session (60 min) and two home-based sessions (60 min per session) per week in the first 2 months of the trial. During the remaining months of the 6-month study, participants in the home-based intervention attend a 1-h physical exercise group session per two weeks and two or three exercise sessions (60 min per session) alone at home per week. The cognitive training programs consist of one group session (60 min) and one home-based sessions (60 min per session) per week in the first 2 months of the trial. For the remainder of the 6-month study, participants in the home-based intervention attend a 1-h group cognitive training session per two weeks and one or two cognitive training sessions (60 min per session) alone at home per week.

Other: Multidomain intervention program

Controls

NO INTERVENTION

They are waiting list controls. They will receive the multi-domain intervention after this study.

Interventions

Multidomain intervention program for physical exercise, cognitive training, nutrition, vascular and metabolic risk controls, and motivation

Facility-based InterventionHome-based Intervention

Eligibility Criteria

Age60 Years - 79 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 60-79
  • Having at least one among the following dementia risks,
  • hypertension
  • Diabetes Mellitus
  • Dyslipidemia
  • Obesity
  • Abdominal obesity
  • Metabolic syndrome
  • Smoking
  • educational level ≤ 9 years
  • Physical inactivity
  • Social inactivity
  • Independent activities of daily living
  • Mini-Mental State Examination score better than1.5 standard deviations below age and education-adjusted normative means
  • Can read and write Korean
  • +2 more criteria

You may not qualify if:

  • Major psychiatric illness such as major depressive disorders
  • Dementia
  • Substantial cognitive decline
  • Other degenerative disease (e.g., Parkinson's disease)
  • Malignancy within 5 years
  • Cardiac stent or revascularization within 1 year
  • Serious or unstable symptomatic cardiovascular disease
  • Other serious or unstable medical disease such as acute or severe asthma, active gastric ulcer, severe liver disease, or severe renal disease
  • Severe loss of vision, hearing, or communicative disability
  • Any conditions preventing cooperation as judged by the study physician
  • Significant laboratory abnormality that may result in cognitive impairment
  • Unable to participate in exercise program safely
  • Coincident participation in any other intervention trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Chonnam National University Hospital

Gwangju, South Korea

Location

Inha Univeristy Hospital

Incheon, 400-711, South Korea

Location

Dong-A University Hospital

Pusan, South Korea

Location

Bobath Memorial Hospital

Seongnam, South Korea

Location

Ewha Womans University Mokdong Hospital

Seoul, South Korea

Location

Ajou University Hospital

Suwon, South Korea

Location

Related Publications (2)

  • Han MH, Lee EH, Park HH, Choi SH, Koh SH. Relationship between telomere shortening and early subjective depressive symptoms and cognitive complaints in older adults. Aging (Albany NY). 2023 Feb 17;15(4):914-931. doi: 10.18632/aging.204533. Epub 2023 Feb 17.

  • Park HK, Choi SH, Kim S, Park U, Kang SW, Jeong JH, Moon SY, Hong CH, Song HS, Chun BO, Lee SM, Choi M, Park KW, Kim BC, Cho SH, Na HR, Park YK. Functional brain changes using electroencephalography after a 24-week multidomain intervention program to prevent dementia. Front Aging Neurosci. 2022 Oct 12;14:892590. doi: 10.3389/fnagi.2022.892590. eCollection 2022.

MeSH Terms

Conditions

Cognitive DysfunctionDementia

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Jee Hyang Jeong, MD, PhD

    Ewha Womans University Hospital

    PRINCIPAL INVESTIGATOR
  • So Young Moon, MD, PhD

    Ajou University Hospital, Neurology

    PRINCIPAL INVESTIGATOR
  • Chang Hyung Hong, MD, PhD

    Ajou University Hospital, Psychiatry

    PRINCIPAL INVESTIGATOR
  • Hae Ri Na, MD, PhD

    Bobath Memorial Hospital

    PRINCIPAL INVESTIGATOR
  • Kyung Won Park, MD, PhD

    Dong-A University Hospital

    PRINCIPAL INVESTIGATOR
  • Byung Chae Kim, MD, PhD

    Chonnam National University Hospital

    PRINCIPAL INVESTIGATOR
  • Yoo Kyoung Park, PhD

    Kyunghee University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Independent raters are blinded to the group of participants.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: They will be randomly allocated to facility-based multidomain intervention group, home-based intervention group, and a regular health advice group (referred to as control group) at a ratio of 1:1:1.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor Seong Hye Choi

Study Record Dates

First Submitted

May 28, 2019

First Posted

June 10, 2019

Study Start

May 29, 2019

Primary Completion

February 14, 2020

Study Completion

February 25, 2020

Last Updated

March 4, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

We will decide it later.

Locations